0132 GMT - IHH Healthcare may see stronger earnings in 2H, supported by likely higher revenue, continued patient volume growth from increased bed capacity and better margins due to the turnaround of its underperforming assets, CIMB Securities analysts Yee Sin Seh and Walter Aw Lik Hsin say in a note. The healthcare service provider's long-term earnings outlook may stay strong, driven by beds addition within existing facilities and robust operational metrics. CIMB maintains a buy rating on IHH and keeps target price at MYR7.85. Shares are 0.2% higher at MYR6.30.(yingxian.wong@wsj.com)
(END) Dow Jones Newswires
August 29, 2024 21:32 ET (01:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments